Vabysmo (faricimab)

pCPA File Number: 21977

Negotiation Status:

Concluded with an LOI

Indication(s):

Neovascular (Wet) Age-related Macular Degeneration (nAMD)

Sponsor/Manufacturer:

Hoffmann-La Roche Ltd.

CDA-AMC Project Number:

SR0719-000

pCPA Engagement Letter Issued:

2023-02-17

Negotiation Process Concluded:

2023-04-27